Location
United States, North America
Check Size
$100K - $10M
Investment Stage
Focus Areas
About Investor
Sara Nayeem is a Partner at Avoro Ventures, where she focuses on biopharmaceutical investments across early through late-stage and crossover rounds, typically deploying $100K–$10M. She joined Avoro in 2021 after a 12-year tenure at New Enterprise Associates (NEA), where she played a central role in approximately 25 investments resulting in numerous IPOs and acquisitions. Before entering venture capital, she worked in investment banking at Merrill Lynch and Morgan Stanley and holds an MD/MBA from Yale and a BA in Biology from Harvard. She currently serves on several boards, including Vanqua Bio, and acts as a board observer for others like Scribe Therapeutics.
Previous investments
Similar Investors
Abdul Ly
Seed
,Series A
,Paul Straub
Pre Seed
,Seed
,Riley Florsheim
Pre Seed
,Seed
,Danielle Graham
Pre Seed
,Seed
,JJ Richa
Pre Seed
,Seed
,Alicia Lenis
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free